Americas vs Luxembourg: Proportion of the target population who received a 3rd dose of
Americas
79.0%
in 2024
Luxembourg
97.0%
in 2024
Americas rank
14th
Luxembourg rank
11th
Proportion of the target population who received a 3rd dose of over time
- Americas
- Luxembourg
How they compare
Luxembourg currently reports 97.0% against 79.0% in Americas, a difference of 18.0%.
That makes Luxembourg's figure about 1.2 times Americas's.
Across all 17 years both countries report, Luxembourg has been ahead every year.
Americas ranks 14th and Luxembourg ranks 11th of 37 groups.
Luxembourg has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Americas | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.5% | 86.0% | 54.5% | Luxembourg |
| 2010s | 77.2% | 93.4% | 16.2% | Luxembourg |
| 2020s | 76.4% | 96.6% | 20.2% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Americas or Luxembourg?
- Luxembourg, at 97.0% against 79.0% in Americas as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Americas and Luxembourg?
- 18.0%, with Luxembourg ahead.
- How many years of comparable data are there for Americas and Luxembourg?
- 17 years are reported by both, from 2008 to 2024.
- How do Americas and Luxembourg rank globally for proportion of the target population who received a 3rd dose of?
- Americas ranks 14th and Luxembourg ranks 11th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.